US2014179639A1PendingUtilityA1
Meloxicam for the treatment of respiratory diseases in pigs
Est. expiryFeb 23, 2024(expired)· nominal 20-yr term from priority
A61P 31/14A61P 31/00A61P 31/12A61P 31/10A61P 11/00A61K 45/06A61K 31/65A61K 31/5415
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating or preventing a respiratory disease in a pig is described that includes administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of treating or preventing a respiratory disease in a pig, the method comprising administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically acceptable salt thereof.
2 . The method according to claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered systemically or orally.
3 . The method according to claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered in a daily dose ranging from 0.01 mg/kg to 5.0 mg/kg.
4 . The method according to claim 2 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered in a daily dose ranging from 0.01 mg/kg to 5.0 mg/kg.
5 . The method according to claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered by injection.
6 . The method according to claim 2 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered by injection.
7 . The method according to claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered via drinking water or as top dressing on feed in soluble granules.
8 . The method according to claim 2 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered via drinking water or as top dressing on feed in soluble granules.
9 . The method according to claim 1 , wherein an antibiotic is administered in conjunction with the meloxicam or a pharmaceutically acceptable salt thereof.
10 . The method according to claim 2 , wherein an antibiotic is administered in conjunction with the meloxicam or a pharmaceutically acceptable salt thereof.
11 . The method according to claim 9 , wherein the antibiotic is selected from the group consisting of β-lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and macrolides.
12 . The method according to claim 10 , wherein the antibiotic is selected from the group consisting of β-lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and macrolides.
13 . The method according to claim 9 , wherein the antibiotic is oxytetracycline or chlorotetracycline.
14 . The method according to claim 10 , wherein the antibiotic is oxytetracycline or chlorotetracycline.
15 . The method according to claim 1 , wherein the disease is Porcine Respiratory Disease Complex and the pig is a growing or fattening pig.
16 . The method according to claim 2 , wherein the disease is Porcine Respiratory Disease Complex and the pig is a growing or fattening pig.
17 . The method according to claim 1 , wherein the disease is caused by mycoplasmas, bacteria, or viruses.
18 . The method according to claim 2 , wherein the disease is caused by mycoplasmas, bacteria, or viruses.
19 . The method according to claim 1 , wherein the disease is caused by Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, Arcanobacterium pyogenes, Swine Influenza Virus, Aujetzky's Virus, Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus, or Transmissible Gastroenteritis and Porcine Respiratory Coronavirus.
20 . The method according to claim 2 , wherein the disease is caused by Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, Arcanobacterium pyogenes, Swine Influenza Virus, Aujetzky's Virus, Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus, or Transmissible Gastroenteritis and Porcine Respiratory Coronavirus.
21 . The method according to claim 1 , wherein the disease is caused by Actinobacillus spp., Streptococcus spp., or Staphylococcus spp.
22 . The method according to claim 2 , wherein the disease is caused by Actinobacillus spp., Streptococcus spp., or Staphylococcus spp.Join the waitlist — get patent alerts
Track US2014179639A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.